PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Inhibition in Hyperglycemic Mice Increases the Risk of Hemorrhagic Transformation of Ischemic Stroke.

Brice Nativel Stéphane Ramin-Mangata David Couret Cynthia Planesse Mathias Roche Antonio Gallo Olivier Meilhac Gilles Lambert Steeve Bourane

Stroke

Université de La Réunion, INSERM, UMR 1188 Diabète athérothrombose Réunion Océan Indien (DéTROI), Saint-Denis de La Réunion, France (B.N., S.R.-M., D.C., C.P., M.R., A.G., O.M., G.L., S.B.).

Published: August 2021

[Figure: see text].

Download full-text PDF	Source
http://dx.doi.org/10.1161/STROKEAHA.121.035677	DOI Listing

Publication Analysis

Top Keywords

pcsk9 proprotein

proprotein convertase

convertase subtilisin

subtilisin kexin

kexin type

type inhibition

inhibition hyperglycemic

hyperglycemic mice

mice increases

increases risk

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!